(State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||
(Address of principal executive offices) | (Zip Code) | |||||||||||||
Registrant's telephone number, including area code: ( | ||||||||||||||
Not Applicable (Former Name or Former Address, if Changed Since Last Report) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act: | ||||||||||||||
Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||||||||
Item 5.07 | Submission of Matters to a Vote of Security Holders. |
Proposal No. 1 | Election of Dr. Clay Siegall and Dr. Sapna Srivastava as Class III directors to the Company’s board of directors, each to serve until the 2027 annual meeting of stockholders; and | |||||||
Proposal No. 2 | Ratification of the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. |
Nominee | Votes For | Votes Withheld | Broker Non-Votes | |||||||||||||||||
Dr. Clay Siegall | 11,005,384 | 2,747,643 | 2,104,922 | |||||||||||||||||
Dr. Sapna Srivastava | 13,160,829 | 590,088 | 2,107,032 |
Votes For | Votes Against | Abstentions | ||||||||||||
15,856,440 | 1,476 | 33 |
TOURMALINE BIO, INC. | ||||||||
Date: June 7, 2024 | By: | /s/ Brad Middlekauff | ||||||
Name: | Brad Middlekauff | |||||||
Title: | Corporate Secretary |
Cover |
Jun. 05, 2024 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | Jun. 05, 2024 |
Entity Registrant Name | TOURMALINE BIO, INC. |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-40384 |
Entity Tax Identification Number | 83-2377352 |
Entity Address, Address Line One | 27 West 24th Street |
Entity Address, Address Line Two | Suite 702 |
Entity Address, City or Town | New York |
Entity Address, State or Province | NY |
Entity Address, Postal Zip Code | 10010 |
City Area Code | 646 |
Local Phone Number | 481-9832 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $0.0001 per share |
Trading Symbol | TRML |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Amendment Flag | false |
Entity Central Index Key | 0001827506 |
I.'B:+J7"A98TT@Q#*IS?PVU[
M)B,><,/%BCQ#>2M.HU(>7*62IW!^#S?JJ6+7 4P/@_6UW_0P$<+V[&6Y/),_
M7*^2K#!]#_?HK\C&6J= 5@F(RU8!^H79^[@SS[F!_BV7Q/._7_Q 9BQ(H=YV
MI=M97,G6)S3;F9'!^Q5)J"(?-$H9^=:]<<$G2 +CU6NJ4.ZB!_BX:<\5#6W]
MS7;Q0I967Y7 Z_,31G)R$,#=^3AE9+0-UE2LV-F-9(709#![&/R*,156[U]D
M]:.8J96=I9] 38)D**$BO+DXH)&I6C>"J/W<9\^DFT)9!".RMD&;7\\*,7"
MU2K70>'[/F[9 UB=8;9"'R.Z*D7!!2I1"L/W+]KZ#P%&02\:@U-LR2=6GC9<
MRBZ\CM]NNJ7-L79R"K>_:#Q36RV:1&P):NY-&T:L]C\2[&^,3+*#^4(:..9G
MEVM&P -8?20$3;8T.P6BP^0"X99K>]9!:G
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end